Back to School: How biopharma can reboot drug development. Access exclusive analysis here

INKP-100 sodium phosphate tablet: INKP began enrolling 90 patients in a Phase II dose-ranging trial

InKine Pharmaceutical Co. Inc. (INKP), Blue

Read the full 63 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE